Everyday monitoring disease activity of chronic inflammatory diseases such as Rheumatoid Arthritis (RA) is a tempting approach for every patient for attaining personalized treatment strategies. Still underdeveloped area of RA biomarkers needs sensitive and specific analytes. CTHRC1 was found earlier expressed in activated synoviocytes and present in circulation that makes it potential valuable RA marker.